Insider Activity of FREEMAN KEVIN D
According to the SEC Form 4 filings, FREEMAN KEVIN D, being in a position of
- director at Galectin Therapeutics Inc.,оver the last 12 months, has bought 16300 shares for $43,832, and sold 0 shares,over all time since 2013-05-28, has bought 128692 shares for $332,476, and sold 0 shares.
The largest purchase of all time was on 2019-05-31 and amounted to 9136 shares of Galectin Therapeutics Inc. for $39,102.
Biography of FREEMAN KEVIN D
No biography is available at this moment.